BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 10357920)

  • 1. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Cre/Lox recombination in the mouse proximal tubule.
    Rubera I; Poujeol C; Bertin G; Hasseine L; Counillon L; Poujeol P; Tauc M
    J Am Soc Nephrol; 2004 Aug; 15(8):2050-6. PubMed ID: 15284291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
    Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
    Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
    Zhou J; Cheng X; Lu YX; Huang CF; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
    Utomo AR; Nikitin AY; Lee WH
    Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.
    Novak A; Guo C; Yang W; Nagy A; Lobe CG
    Genesis; 2000; 28(3-4):147-55. PubMed ID: 11105057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z/AP, a double reporter for cre-mediated recombination.
    Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
    Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of oocyte-specifically expressed cre transgenic zebrafish for female germline excision of loxP-flanked transgene.
    Liu X; Li Z; Emelyanov A; Parinov S; Gong Z
    Dev Dyn; 2008 Oct; 237(10):2955-62. PubMed ID: 18816824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
    Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
    Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; NoaĆ­n D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
    Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
    Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of CETD transgenic mouse line allowing ablation of any type of specific cell population.
    Sato M; Tanigawa M
    Mol Reprod Dev; 2005 Sep; 72(1):54-67. PubMed ID: 15902717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
    Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.